Vaxart, Inc.
Overview
Vaxart, Inc. is a clinical-stage biotechnology company focused on developing oral recombinant vaccines administered by tablet rather than by injection. The company aims to transform vaccine delivery with its proprietary oral vaccine platform and is actively working on vaccines for various infectious diseases.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Vaxart, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Vaxart, Inc.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.